Literature DB >> 28225966

Chronic tophaceous gout in patients with psoriasis.

Laís Cruz Lobato1, Jéssica Castiel Coutinho1, Maria Zeli Moreira Frota2, Antonio Pedro Mendes Schettini3, Mônica Santos4,5.   

Abstract

Psoriasis is a chronic inflammatory disease of multifactorial etiology influenced by genetic, immunological, and environmental factors. We report the case of a patient with psoriasis for more than 25 years who developed hyperuricemia and chronic tophaceous gout with unusual appearance. In psoriasis, hyperuricemia may occur by increased epidermal cell turnover, which accelerates purine metabolism and has uric acid as the product of its catabolism. The association of psoriasis with hyperuricemia can trigger the onset of gouty arthritis, and pose a greater risk of developing other inflammatory comorbidities. Therefore, it is important to periodically investigate uric acid levels in order to treat changes triggered by hyperuricemia.

Entities:  

Mesh:

Year:  2017        PMID: 28225966      PMCID: PMC5312188          DOI: 10.1590/abd1806-4841.20174895

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


  10 in total

1.  Coexisting gout, erythrodermic psoriasis and psoriatic arthritis.

Authors:  Mei Liu; Jiu-Hong Li; Bo Li; Chun-Di He; Ting Xiao; Hong-Duo Chen
Journal:  Eur J Dermatol       Date:  2008-12-23       Impact factor: 3.328

2.  Cross-sectional study on the correlation of serum uric acid with disease severity in Korean patients with psoriasis.

Authors:  H H Kwon; I H Kwon; J W Choi; J I Youn
Journal:  Clin Exp Dermatol       Date:  2011-07       Impact factor: 3.470

Review 3.  Genetic and epigenetic basis of psoriasis pathogenesis.

Authors:  Aditi Chandra; Aditi Ray; Swapan Senapati; Raghunath Chatterjee
Journal:  Mol Immunol       Date:  2015-01-13       Impact factor: 4.407

4.  C-reactive protein and uric Acid levels in patients with psoriasis.

Authors:  V K Jain; Harbans Lal
Journal:  Indian J Clin Biochem       Date:  2011-05-04

Review 5.  Gout as autoinflammatory disease: new mechanisms for more appropriated treatment targets.

Authors:  Leonardo Punzi; Anna Scanu; Roberta Ramonda; Francesca Oliviero
Journal:  Autoimmun Rev       Date:  2012-08-02       Impact factor: 9.754

Review 6.  Uric acid and cardiovascular risk.

Authors:  Daniel I Feig; Duk-Hee Kang; Richard J Johnson
Journal:  N Engl J Med       Date:  2008-10-23       Impact factor: 91.245

7.  Hyperuricemia in patients with chronic plaque psoriasis.

Authors:  Paolo Gisondi; Giovanni Targher; Anna Cagalli; Giampiero Girolomoni
Journal:  J Am Acad Dermatol       Date:  2013-10-30       Impact factor: 11.527

Review 8.  Psoriasis and Metabolic Syndrome--scientific evidence and therapeutic implications.

Authors:  V M Voiculescu; M Lupu; L Papagheorghe; C Giurcaneanu; E Micu
Journal:  J Med Life       Date:  2014 Oct-Dec

9.  Obesity and dyslipidemia in patients with psoriasis treated at a dermatologic clinic in Manaus.

Authors:  Mônica Santos; Hannah Monteiro Fonseca; Alex Panizza Jalkh; Gabriela Piraice Gomes; Andrea de Souza Cavalcante
Journal:  An Bras Dermatol       Date:  2013 Nov-Dec       Impact factor: 1.896

10.  Comorbidities in patients with gout prior to and following diagnosis: case-control study.

Authors:  Chang-Fu Kuo; Matthew J Grainge; Christian Mallen; Weiya Zhang; Michael Doherty
Journal:  Ann Rheum Dis       Date:  2014-11-14       Impact factor: 19.103

  10 in total
  2 in total

Review 1.  At the crossroads of gout and psoriatic arthritis: "psout".

Authors:  Renaud Felten; Pierre-Marie Duret; Jacques-Eric Gottenberg; Lionel Spielmann; Laurent Messer
Journal:  Clin Rheumatol       Date:  2020-02-15       Impact factor: 2.980

2.  Psoriatic arthritis with hyperuricemia: more peripheral, destructive, and challenging to treat.

Authors:  L Messer; R Felten; L Widawski; T Fabacher; L Spielmann; J E Gottenberg; J Sibilia; P M Duret
Journal:  Clin Rheumatol       Date:  2022-01-20       Impact factor: 3.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.